Evidence map›Paper›PMID 28972118›Full record

ArticleJournal of lipid research2017

Vulnerability of

Zeljka Korade, Thiago C Genaro-Mattos, Keri A Tallman, Wei Liu, Krassimira A Garbett, Katalin Koczok, Istvan Balogh, Karoly Mirnics, Ned A Porter

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Sterol biosynthesis, brain development, and disease.The Journal of clinical investigation · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Trazodone effects on developing brain.Translational psychiatry · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Zeljka KoradeDepartments of Pediatrics and Biochemistry and Molecular Biology University of Nebraska Medical Center, Omaha, NE 68198.
Thiago C Genaro-MattosDepartment of Chemistry and Vanderbilt Institute of Chemical Biology Vanderbilt University, Nashville, TN 37235.
Keri A TallmanDepartment of Chemistry and Vanderbilt Institute of Chemical Biology Vanderbilt University, Nashville, TN 37235.
Wei LiuDepartment of Chemistry and Vanderbilt Institute of Chemical Biology Vanderbilt University, Nashville, TN 37235.
Krassimira A GarbettDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37235.
Katalin KoczokDepartment of Laboratory Medicine, Division of Clinical Genetics, University of Debrecen, Debrecen 4032, Hungary.
Istvan BaloghDepartment of Laboratory Medicine, Division of Clinical Genetics, University of Debrecen, Debrecen 4032, Hungary.
Karoly MirnicsMunroe-Meyer Institute for Genetics and Rehabilitation, University of Nebraska Medical Center, Omaha, NE 68198.
Ned A PorterDepartment of Chemistry and Vanderbilt Institute of Chemical Biology Vanderbilt University, Nashville, TN 37235 n.porter@vanderbilt.edu.
Vanderbilt University · USUniversity of Debrecen · HUNebraska Medical Center · USUniversity of Nebraska Medical Center · US

Funding

Research Project: Sensory and Multisensory Contributions to AutismU54HD083211 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DYKENS, ELISABETH MAY · 2015 to 2019
$7.1M
Neocortical Transcriptome Changes in SchizophreniaR01MH067234 · NIMH · VANDERBILT UNIVERSITY · PI MIRNICS, KAROLY · 2003 to 2021
$4.7M
SLOS and Neuronal Oxidative StressR01HD064727 · NICHD · VANDERBILT UNIVERSITY · PI PORTER, NED ALLEN · 2010 to 2020
$3.7M
Vulnerability of DHCR7+/- mutation carriers to aripiprazole and trazodone treatmentR01MH110636 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI MIRNICS, KAROLY, PORTER, NED ALLEN · 2017 to 2021
$2.7M
Sterols, Neurogenesis and Environmental AgentsR01ES024133 · NIEHS · VANDERBILT UNIVERSITY · PI KORADE, ZELJKA, PORTER, NED ALLEN · 2015 to 2017
$1.1M
NICHD NIH HHS R01 HD064727NICHD NIH HHS U54 HD083211NIEHS NIH HHS R01 ES024133NIMH NIH HHS R01 MH067234NIMH NIH HHS R01 MH110636
6 · The paper itself

Abstract

Smith-Lemli-Opitz syndrome is a recessive disorder caused by mutations in 7-dehydrocholesterol reductase (DHCR)7 with a heterozygous (HET) carrier frequency of 1-3%. A defective DHCR7 causes accumulation of 7-dehydrocholesterol (DHC), which is a highly oxidizable and toxic compound. Recent studies suggest that several antipsychotics, including the highly prescribed pharmaceuticals, aripiprazole (ARI) and trazodone (TRZ), increase 7-DHC levels in vitro and in humans. Our investigation was designed to compare the effects of ARI and TRZ on cholesterol (Chol) synthesis in fibroblasts from

Indexed as

MutationAdultAripiprazoleCholesterolEnzyme InhibitorsFemaleFibroblastsHumansMaleMiddle AgedOxidoreductases Acting on CH-CH Group DonorsSmith-Lemli-Opitz SyndromeTrazodone7-dehydrocholesterol reductaseAripiprazoleCholesterolEnzyme InhibitorsOxidoreductases Acting on CH-CH Group DonorsTrazodone7-dehydrocholesterol7-dehydrocholesterol reductaseantipsychoticsfibroblasts

Identifiers

PMID28972118
PMCPMC5665669
OpenAlexW2762854480

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.